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To the Editor: We read with interest the discussions
of Dr. Hou regarding the best ways to improve organ
donations [1]. As usually happens in this field, most strat-
egies are cited to imply that they did not achieve signifi- Bone mass evolution after renal
cant improvements. Rather surprising, the Spanish expe-
rience is not even considered, despite the fact that Spain transplantation
is the only large country (40 million citizens) in the world
with a sustained and progressive increase of cadaveric
To the Editor: Now that tailoring immunosuppressionorgan donation rates during the last decade.
Since the National Transplant Organization was estab- is possible, efforts have concentrated on the prevention
lished in 1989, together with a national network of in- of post-transplant complications, including bone demin-
hospital, specifically trained, part-time, dedicated, and eralization. In this context, the recent study by Westeel et
strongly motivated physicians in charge of organ pro- al suggests that cyclosporine-steroid immunosuppression
curement [2], Spain has increased its organ donations may prevent post-transplant osteopenia [1].
from 14 to 33.6 organ donors per million people in 1999, Unfortunately, this conclusion is not convincing. It rests
a 142% increase [3]. This organ donor rate is by far the only upon data collected between 3 and 24 months post-
highest in the world (the United States has 21.8 per transplantation. When the first post-transplant months
million people, Canada has 13.8, and the mean of the are included, all published studies agree that cyclosporine-
other European countries is 14.3), which has also re- steroid–based immunosuppression is consistently associ-
sulted in the highest transplant rates of cadaveric kidney, ated with bone loss [2, 3]. We have confirmed this conclu-
liver, heart, and lungs [4]. There was no change in legisla- sion in 44 unselected graft recipients (Fig. 1).
tion during this period and, as in most European coun-
The bone loss between 3 and 24 months post-trans-tries, permission from the family is always obtained be-
plantation that can be anticipated from the results offore donation.
previous studies averages 1.5% [2, 3]. The results ofThe number of renal transplants rose from 1039 in
Westeel et al that were collected during this interval are1989 to 2023 ten years later, 99% cadaveric (50.6 per
thus of borderline significance when the precision errormillion people versus 29.9 in the United States), a sig-
of the methods used to evaluate bone mass is considerednificant and sustained increase that, at least in our opin-
(0.4 and 6 2 to 4% for the dual energy x-ray absorpti-ion, deserves a reference in reviews from authors of
ometry and the quantitative computed tomography [4],possible methods to expand the donor pool. The “Span-
respectively).ish Model” results from the efforts of many to overcome
Finally, these authors’ conclusions are limited by pa-obstacles such as untrained or under trained staff, un-
tient selection, specifically excluding osteopenic post-identified donors, and the reluctance to approach griev-
ing family members. menopausal women. Indeed, the independent effect on
bone mass when the normal ovarian cycle is resumed in
Rafael Matesanz and Blanca Miranda pre-menopausal women, as well as the prescription of
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potential osteogenic drugs (such as statins or thiazides)
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throughout the first post-transplant year will find mini-
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